MIRM

MIRUM PHARMACEUTICALS (MIRM) Investor Questions

Review MIRUM PHARMACEUTICALS (MIRM) faq with company data, supporting context and links to related investor research.

Research record updated: . Individual measures may refer to different reporting periods.

Company
MIRUM PHARMACEUTICALS
Sector
Healthcare
Industry
Biotechnology
Overall BTI score
46
Annual revenue
$521.31M
Annual net income
$-23.36M
Annual free cash flow
$54.87M

MIRUM PHARMACEUTICALS (MIRM) Investor Questions research

MIRUM PHARMACEUTICALS trades under the ticker MIRM. The company is classified in the Healthcare sector and the Biotechnology industry.

Investors commonly review MIRM through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.